Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Cynosure, Inc.(CYNO)

 
123Jump Rating: - Value Gap   Underwriters: Citigroup
      UBS Investment Bank
Status: Priced  
 
Address: 5 Carlisle Rd.
FiledDate: 08/11/2005
  Westford,
   
  MA 01886
Filed Price Range ($): $12.00-14.00
       
Telephone: 978-256-4200 Filed Offer Amount ($ Million): $75.00
       
Fax: 978-256-6556 Shares Offered (Millions): 5
       
Websites: www.cynosurelaser.com Shares Outstanding (Millions):
       
Management: Michael Davin, Chair./Pres./CEO
IPO Date: 12/08/2005
  Timothy Baker, EVP/CFO
   
  Douglas Delaney, EVP
Final Offer Price ($): $15.00
       
Industry: Healthcare Final Offer Size (Millions of Shares): 0.00
       
Employees: 184 Final Offer Amount ($ Million): $0.00
       
Competitors: Candela Corporation
S-1 Forms:
  Cutera
   
  Palomar Medical
 
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Major Stock Holders   (Prior To Offering)

Name

Class A
Andrea Cangioli 78.30%
El.En. S.p.A. 78.30%
Gabriele Clementi 78.30%
George Cho 1.90%
Leonardo Masotti 78.30%

Major Stock Holders  (After Offering)

Name

Common Stock Class A Class B Class C Class L ADS
Douglas J. Delaney 73,131 NA NA NA NA NA
George Cho 117,768 NA NA NA NA NA
John T. Theroux 45,000 NA NA NA NA NA
Michael R. Davin 111,111 NA NA NA NA NA
Timothy W. Baker 15,000 NA NA NA NA NA

Business Environment

Michael Moretti/Medical Insight, Inc., an aesthetic treatment market research firm, estimates that the number of non-invasive aesthetic treatment procedures worldwide using laser and other light-based technologies will grow from nearly 20 million in 2003 to over 53 million in 2008, representing a compound annual growth rate of over 20%. It is estimated that the worldwide market for aesthetic treatment systems based on laser and other light-based technologies will exceed $550 million in 2005.

Aesthetic treatment procedures that use lasers and other light-based equipment have traditionally been performed by dermatologists and plastic surgeons. Based on published membership information from professional medical organizations, there are more than 18,000 dermatologists and plastic surgeons in the United States. More recently, a broader group of physicians in the United States, including primary care physicians, obstetricians, gynecologists, ophthalmologists and ear, nose and throat specialists, have incorporated aesthetic treatment procedures into their practices. These non-traditional physician customers are largely motivated to offer aesthetic procedures by the potential for a reliable revenue stream that is unaffected by managed care and government payor reimbursement economics.

An aesthetic spa market is also rapidly developing and growing in the United States at dedicated day spa facilities and hotels and resorts. In addition to conventional massage and cosmetic treatments, aesthetic spas are also beginning to offer non-invasive light-based procedures performed by spa technicians and other non-medical professionals. ISPA estimates that there were approximately 12,000 aesthetic spas in North America in 2004, an increase of approximately 26% from 2002.

Company Strategy
The Company develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular lesions and pigmented lesions and temporarily reduce the appearance of cellulite.

Product/Services Portfolio
The Company offers a broad portfolio of aesthetic treatment systems that address a wide variety of applications. Each of the Company’s systems consists of a control console and one or more handpieces. The control consoles are each comprised of a graphical user interface, a laser or other light source, control system software and high voltage electronics. The handpieces on the Company’s laser systems deliver the laser energy through a maneuverable optical fiber to the treatment area.

Practitioners use the Company’s products to perform a variety of non-invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate skin through the treatment of shallow vascular lesions and pigmented lesions and temporarily reduce the appearance of cellulite.

Apogee Elite workstation is the Company’s flagship product for hair removal. It is a two-in-one laser system that contains both an Alexandrite laser, which is best suited for hair removal for patients with light skin types, and an Nd:Yag laser, which is best suited for hair removal for patients with medium and dark skin types or tanned skin.

Cynergy workstation is the Company’s flagship product for the treatment of vascular lesions. The Cynergy system combines a pulse dye laser, which is best suited for treating shallow vascular lesions, such as port wine birthmarks, facial veins and rosacea, and an Nd:Yag laser, which is best suited for treating large or deep veins, such as leg veins.

PhotoSilk Plus system is the Company’s flagship product for skin rejuvenation. The PhotoSilk Plus system is a high-powered pulsed light system that delivers energy over a broad spectrum of wavelengths that are best suited for treatment of shallow vascular lesions and pigmented lesions.

The Company offers the PhotoSilk Plus system with a variety of handpieces that have different wavelength filters and spot sizes. The Company offers three different wavelength filters and three different spot sizes. The range of available wavelength filters allows the practitioner to select the handpiece best suited for the type of treatment to be performed.

TriActive LaserDermology system is the Company’s flagship product for temporarily reducing the appearance of cellulite. The TriActive system contains six low-energy diode lasers, mechanical massage and suction features and localized cooling.

Investment Analysis
Total revenues increased $5.9 million, or 31%, to $25.1 million for the six months ended June 30, 2005, as compared to $19.2 million for the six months ended June 30, 2004.

Cost of revenues increased $1.9 million, or 20%, to $11.6 million in the first six months of 2005, as compared to $9.7 million in the same period in 2004.

Sales and marketing expenses increased $2.3 million, or 40%, to $8.0 million in the first six months of 2005, as compared to $5.8 million in the same period in 2004.

Research and development expenses remained relatively flat, increasing by $0.1 million, or 8%, to $1.5 million in the first six months of 2005, as compared to $1.4 million in the same period in 2004.

Interest expense decreased to $45.0 thousand in the first six months of 2005 from $71.0 thousand in the same period in 2004.

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
2002 22962 12135 -2371 -301 -1867 -0.34999999999999997779553950749686919152736663818359375
2003 27125 15043 -2125 72 -500 -0.0899999999999999966693309261245303787291049957275390625
2004 41633 19957 1211 -276 5296 0.93000000000000004884981308350688777863979339599609375
2005 25080 12180 1268 383 524 0.08000000000000000166533453693773481063544750213623046875
*As of period Ended June 30, 2005

Balance Sheet Data

Year

Cash Acct Recv. Inventory Total Cur Assets Total Cur Liability PPE Total Assets LT Debt SH Equity
2003 2111 5572 6654 15037 10465 2138 18228 0.00 7288
2004 4028 8410 9871 23271 12593 3733 28001 0.00 14640
2005 3198 9732 11663 25619 14203 4255 30649 0.00 15273
*As of period Ended June 30, 2005

Cash Flow Summary

Year

Net Cash-Ops Net Cash-Inv Net Cash-Fin Net Change
2002 1398 -572 1980 2773
2003 -254 -1182 681 -1179
2004 1256 285 93 1917
2005 -57 -1213 -103 -830
*As of period Ended June 30, 2005
 

 

© 1999-2008 123jump.com. All rights reserved